Skip to main content
Log in

Disposition of BRB-I-28 (7-benzyl-7-aza-3-thiabicyclo[3.3.1]nonane hydroperchlorate), a Novel Antiarrhythmic Agent

  • Original Research Article
  • Published:
Drug Investigation Aims and scope Submit manuscript

Summary

The aim of this study was to characterise the pharmacokinetic disposition and tissue distribution of BRB-I-28 (7-benzyl-7-aza-3-thiabicyclo[3.3.1]nonane hydroperchlorate) in rats. The pharmacokinetic disposition was studied by collecting blood samples before and at frequent intervals after intracardiac or oral administration of 14C-labelled BRB-I-28. Two-compartment and 1-compartment pharmacokinetic models were used to describe blood concentration-time profiles after intracardiac and oral administration, respectively. After intracardiac administration, the half-life of elimination (t1/2β)from blood ranged from 4.66 to 9.91 hours and the apparent volume of distribution (Vd(area)) ranged from 3.131 to 6.239 L/kg. Oral dosing resulted in rapid and extensive absorption (bioavailability ± 80%). Distribution of radioactivity into heart, kidney, brain, liver, and perirenal fat was measured by sacrificing rats at various time intervals after oral administration of 14C-labelled BRB-I-28. Extensive distribution of radioactivity occurred in highly perfused organs, particularly liver, kidney and heart. However, levels of radioactivity in brain were low.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Akaike H. A new look at the statistical model identification. Institute of Electrical and Electronics Engineers (IEEE) Transactions on Automatic Control AC-19: 716–723, 1974

    Article  Google Scholar 

  • Bailey BR, Berlin KD, Holt EM, Scherlag BJ, Lazzara R, et al. Synthesis, conformational analysis, and antiarrhythmic properties of 7-benzyl-3-thia-7-azabicyclo[3.3.1]nonane-9-one, 7-benzyl-3-thia-7-azabicyclo[3.3.1] nonane hydroperchlorate, and 7-benzyl-9-phenyl-3-thia-7-azabicyclo[3.3.l]nonan-9-ol hydroperchlorate and derivatives: single crystal X-ray diffraction analysis and evidence for chair-chair and chair-boat conformers in the solid state. Journal of Medicinal Chemistry 27: 758–767, 1984

    Article  PubMed  CAS  Google Scholar 

  • Bigger JT, Hoffman BF. Antiarrhythmic drugs. In Gilman et al. (Eds) The pharmacological basis of therapeutics, pp. 748–783, Macmillan Publishing Company, New York, 1985

    Google Scholar 

  • Bourne DWA. Multiforte, a microcomputer program for modelling and simulation of pharmacokinetic data. Computer Methods and Programs in Biomedicine 23: 277–281, 1986

    Article  PubMed  CAS  Google Scholar 

  • Boxenbaum HG, Riegman S, Elashoff RM. Statistical estimations in pharmacokinetics. Journal of Pharmacokinetics and Bio-pharmaceutics 2: 123, 1974

    Article  CAS  Google Scholar 

  • Edwards CH, Penny DE. In Calculus and analytical geometry, Prentice-Hall, Englewood Cliffs, New Jersey, 1982

    Google Scholar 

  • Gustafsson LL, Walker O, Alvan G, Beermann B, Estevez F. Disposition of chloroquine in man after single intravenous and oral doses. British Journal of Clinical Pharmacology 15: 471–479, 1983

    Article  PubMed  CAS  Google Scholar 

  • McGovern B, Garan H, Kelley E. Adverse reactions during treatment with amiodarone hydrochloride. British Medical Journal 287: 175–180, 1983

    Article  PubMed  CAS  Google Scholar 

  • Nygaarde TW, Sellers D, Cook TS, DiMarco JP. Adverse reactions to antiarrhythmic drugs during therapy for ventricular arrhythmias. Journal of the American Medical Association 256: 55–57, 1986

    Article  Google Scholar 

  • Rakhit A, Holford NHG, Guentert TW, Maloney K, Riegelman S. Pharmacokinetics of quinidine and three of its metabolites in man. Journal of Pharmacokinetics and Biopharmaceutics 12: 1–21, 1984

    PubMed  CAS  Google Scholar 

  • Scherlag BJ, Patterson E, Lazzara R, Bailey BR, Thompson MD, et al. Comparative electrophysiological and hemodynamic actions of BRB-I-28 and lidocaine in the normal and infarcted dog heart. Journal of Electrophysiology 2: 461–477, 1988

    Google Scholar 

  • Schwartz JB, Keefe D, Harrison DC. Adverse effects of antiarrhythmic drugs. Drugs 21: 23–24, 1981

    Article  PubMed  CAS  Google Scholar 

  • Webster LT. Drugs used in the chemotherapy of protozoal infections. In Gilman et al. (Eds) The pharmacological basis of therapeutics, pp. 1029–1048, Macmillan Publishing Company, New York, 1985

    Google Scholar 

  • Yamaoka K, Nakagawa T, Uno T. Application of Akaike’s information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal of Pharmacokinetics and Biopharmaceutics 6: 165, 1978

    PubMed  CAS  Google Scholar 

  • Zisman SA, Berlin KD, Alavi FK, Sangiah S, Clarke CR, et al. Synthesis of 7-benzyl-7-aza-3-thiabicyclo[3.3.1]nonane hydro-perchlorate-6,8,10-14C 3. Journal of Labelled Compounds and Radiopharmaceuticals 27: 885–888, 1989

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alavi, F.K., Clarke, C.R., Sangiah, S. et al. Disposition of BRB-I-28 (7-benzyl-7-aza-3-thiabicyclo[3.3.1]nonane hydroperchlorate), a Novel Antiarrhythmic Agent. Drug Invest. 3, 317–323 (1991). https://doi.org/10.1007/BF03259745

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03259745

Keywords

Navigation